Sravan Kumar Emany, SVP & CFO at Ironwood Pharma, holds 338.85K shares in Ironwood Pharma (Ticker: IRWD), holds 177.57K shares in Assertio Therapeutics (Ticker: ASRT).

See the Hottest Stocks Based on Insider Trading >

Sravan Kumar Emany
Ironwood Pharma (IRWD)
SVP & CFO

Ranked #41,415 out of 98,743 Corporate Insiders

Profitable Transactions

1 out of 3 Profitable Transactions

Average Return

+4.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

93.32%

IRWD

6.68%

ASRT

A breakdown of Sravan Kumar Emany's holdings

See the Top Stocks by Insiders

Insider Roles

Ironwood Pharma
(IRWD)

SVP & CFO

Assertio Therapeutics
(ASRT)

Director

Roles that Sravan Kumar Emany holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ironwood Pharma
(IRWD)

Rating:Informative Sell

Date:Nov 23, 2022 - Nov 23, 2023

Return:+25.60%

The most profitable trade made by Sravan Kumar Emany

See the Latest Stocks Traded by Insiders

Sravan Kumar Emany's Trading History

IRWD

Ironwood Pharma

Mar 12, 2024

SVP & CFO

Uninformative Buy

―

$2.75M

ASRT

Assertio Therapeutics

Nov 16, 2023

Director

Uninformative Buy

―

$197.10K

List of latest transactions for each holding click on a transaction to see Sravan Kumar Emany's performance on stock

See All Insider Trading from Today

Sravan Kumar Emany insider profile FAQ

What is the percentage of profitable transactions made by Sravan Kumar Emany?

The percentage of profitable transactions made by Sravan Kumar Emany is 33%.

What is the average return per transaction made by Sravan Kumar Emany?

The average return per transaction made by Sravan Kumar Emany is 4.70%.

What stocks does Sravan Kumar Emany hold?

Sravan Kumar Emany holds: IRWD, ASRT stocks.

What was Sravan Kumar Emany’s latest transaction?

Sravan Kumar Emany latest transaction was an Uninformative Buy of ―.

What was Sravan Kumar Emany's most profitable transaction?

Sravan Kumar Emany’s most profitable transaction was an Informative Sell of IRWD stock on November 23, 2022. The return on the trade was 25.60%.

What is Sravan Kumar Emany's role in Ironwood Pharma?

Sravan Kumar Emany's role in Ironwood Pharma is SVP & CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Sravan Kumar Emany Insider Profile

Sravan Kumar Emany Ironwood Pharma (IRWD)SVP & CFO